168 related articles for article (PubMed ID: 11280732)
1. Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.
Koukourakis MI; Giatromanolaki A; Skarlatos J; Corti L; Blandamura S; Piazza M; Gatter KC; Harris AL
Cancer Res; 2001 Mar; 61(5):1830-2. PubMed ID: 11280732
[TBL] [Abstract][Full Text] [Related]
2. Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy.
Koukourakis MI; Corti L; Skarlatos J; Giatromanolaki A; Krammer B; Blandamura S; Piazza M; Verwanger T; Schnitzhofer G; Kostandelos J; Beroukas K
Anticancer Res; 2001; 21(1B):663-8. PubMed ID: 11299823
[TBL] [Abstract][Full Text] [Related]
3. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
4. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
[TBL] [Abstract][Full Text] [Related]
5. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
6. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
7. Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma.
Matsuyama T; Nakanishi K; Hayashi T; Yoshizumi Y; Aiko S; Sugiura Y; Tanimoto T; Uenoyama M; Ozeki Y; Maehara T
Cancer Sci; 2005 Mar; 96(3):176-82. PubMed ID: 15771621
[TBL] [Abstract][Full Text] [Related]
8. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
[TBL] [Abstract][Full Text] [Related]
9. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.
Birner P; Schindl M; Obermair A; Breitenecker G; Oberhuber G
Clin Cancer Res; 2001 Jun; 7(6):1661-8. PubMed ID: 11410504
[TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
Theodoropoulos VE; Lazaris ACh; Sofras F; Gerzelis I; Tsoukala V; Ghikonti I; Manikas K; Kastriotis I
Eur Urol; 2004 Aug; 46(2):200-8. PubMed ID: 15245814
[TBL] [Abstract][Full Text] [Related]
12. Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.
Giatromanolaki A; Harris AL
Anticancer Res; 2001; 21(6B):4317-24. PubMed ID: 11908686
[TBL] [Abstract][Full Text] [Related]
13. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae.
Rajakumar A; Brandon HM; Daftary A; Ness R; Conrad KP
Placenta; 2004 Nov; 25(10):763-9. PubMed ID: 15451190
[TBL] [Abstract][Full Text] [Related]
15. The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis.
Salnikow K; Davidson T; Zhang Q; Chen LC; Su W; Costa M
Cancer Res; 2003 Jul; 63(13):3524-30. PubMed ID: 12839937
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
17. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.
Aebersold DM; Burri P; Beer KT; Laissue J; Djonov V; Greiner RH; Semenza GL
Cancer Res; 2001 Apr; 61(7):2911-6. PubMed ID: 11306467
[TBL] [Abstract][Full Text] [Related]
18. [Expression of HIF-1 alpha and its relationship to apoptosis and proliferation in lung cancer].
Fan LF; Diao LM; Chen DJ; Liu MQ; Zhu LQ; Li HG; Tang ZJ; Xia D; Liu X; Chen HL
Ai Zheng; 2002 Mar; 21(3):254-8. PubMed ID: 12451989
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression.
Camenisch G; Stroka DM; Gassmann M; Wenger RH
Pflugers Arch; 2001 Nov; 443(2):240-9. PubMed ID: 11713650
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
